speb/financial-data huggingface dataset:
Financial ratios for AXTI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 65423184
Market cap (USD): 141968309.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXTI — quarterly report dated 2025-03-31
Total revenue: 19356000
Gross profit: -1241000
Operating income: -10275000
Net income: -8798000
Capital expenditures: 510000
Operating cash flow: -3346000
Depreciation & amortization: 2223000
Net tangible assets: 185037000
Owner earnings: -7085000
Return on net tangible assets (%): -3.8289639369423414
Buffett classification: The Gruesome
Stock price: 1.41
Shares outstanding: 65423184
Book value: 246172000
P/B ratio: 0.37472453991518123
Market cap (USD): 92246689.44
Debt to equity: 0.223043238061193
Current ratio: 1.9869644945253535
Quick ratio: 0.9184915488466036
Interest coverage ratio: -38.19702602230483
COGS to revenue (%): 106.41144864641454
R&D to revenue (%): 16.108700144657988
SG&A to revenue (%): 30.564166150030996
Free cash flow (dilution-adjusted): -4502000
Buyback yield (%): 0
Retained earnings: -52462000
Inventory turnover: 0.2561529182056735
Receivables turnover: 0.8466080566854743
Capitalized R&D asset: 3118000
ROCI (R&D-adjusted, %): -3.136284034657412
FCF margin (%): -23.25893779706551
Rule of 40 score: -23.25893779706551
Financial ratios for AXTI — quarterly report dated 2025-06-30
Total revenue: 17974000
Gross profit: 1433000
Operating income: -6745000
Net income: -7008000
Capital expenditures: 279000
Operating cash flow: -4576000
Depreciation & amortization: 2260000
Net tangible assets: 179714000
Owner earnings: -5027000
Return on net tangible assets (%): -2.7972222531355375
Buffett classification: The Gruesome
Stock price: 2.09
Shares outstanding: 65423184
Book value: 240631000
P/B ratio: 0.5682329149610814
Market cap (USD): 136734454.56
Debt to equity: 0.24183085304885904
Current ratio: 1.8224334313947348
Quick ratio: 0.8158834326519323
Interest coverage ratio: -33.39108910891089
COGS to revenue (%): 92.02737287192612
R&D to revenue (%): 14.048069433626347
SG&A to revenue (%): 31.450984755758316
Free cash flow (dilution-adjusted): -5488000
Buyback yield (%): 0
Retained earnings: -59470000
Inventory turnover: 0.20659980265540887
Receivables turnover: 0.7885408440817759
Capitalized R&D asset: 4614060
ROCI (R&D-adjusted, %): -2.401258903569677
Rosenberg metric: 0.8576010262989096
FCF margin (%): -30.53299209969957
Revenue growth (%): -7.139904939036991
Rule of 40 score: -37.67289703873656
Financial ratios for AXTI — quarterly report dated 2025-09-30
Total revenue: 27955000
Gross profit: 6224000
Operating income: -1123000
Net income: -1673000
Capital expenditures: 2175000
Operating cash flow: -9151000
Depreciation & amortization: 2306000
Net tangible assets: 179148000
Owner earnings: -1542000
Return on net tangible assets (%): -0.8607408399758858
Buffett classification: The Gruesome
Stock price: 4.49
Shares outstanding: 65423184
Book value: 240456000
P/B ratio: 1.2216376225172174
Market cap (USD): 293750096.16
Debt to equity: 0.2648966962770736
Current ratio: 1.763961035136695
Quick ratio: 0.8492526237676243
Interest coverage ratio: -2.8430379746835444
COGS to revenue (%): 77.73564657485245
R&D to revenue (%): 3.623680915757467
SG&A to revenue (%): 22.657842961903057
Free cash flow (dilution-adjusted): -12064000
Buyback yield (%): 0
Retained earnings: -61376000
Inventory turnover: 0.2798367157721232
Receivables turnover: 0.8261666223364955
Capitalized R&D asset: 3733690
ROCI (R&D-adjusted, %): -0.9208922816110743
Rosenberg metric: 1.8974257425742573
FCF margin (%): -43.15507064925774
Revenue growth (%): 55.53021030377212
Rule of 40 score: 12.375139654514385
Financial ratios for AXTI — annual report dated 2025-12-31
Total revenue: 88326000
Gross profit: 11242000
Operating income: -20615000
Net income: -21260000
Capital expenditures: 5995000
Operating cash flow: -12783000
Depreciation & amortization: 9108000
Net tangible assets: 271617000
Owner earnings: -18147000
Return on net tangible assets (%): -6.6810987530235595
Buffett classification: The Gruesome
Stock price: 16.35
Shares outstanding: 65423184
Book value: 334631000
P/B ratio: 3.1965629556137953
Market cap (USD): 1069669058.4000001
Debt to equity: 0.19369394945477256
Current ratio: 2.72314200196596
Quick ratio: 1.8213295634022155
Interest coverage ratio: -16.40015910898966
COGS to revenue (%): 87.27215089554605
R&D to revenue (%): 10.245001471820302
SG&A to revenue (%): 27.36340375427394
Free cash flow (dilution-adjusted): -22070000
Buyback yield (%): 0
Retained earnings: -64924000
Inventory turnover: 0.9440668209819842
Receivables turnover: 3.289731461134493
Capitalized R&D asset: 22779540
ROCI (R&D-adjusted, %): -6.409199563462933
Rosenberg metric: -0.8659836347383622
FCF margin (%): -24.98698005117406
Revenue growth (%): -11.105967129960447
Rule of 40 score: -36.092947181134505
Financial ratios for AXTI — quarterly report dated 2025-12-31
Total revenue: 23041000
Gross profit: 4826000
Operating income: -2472000
Net income: -3548000
Capital expenditures: 3031000
Operating cash flow: 4290000
Depreciation & amortization: 2319000
Net tangible assets: 271617000
Owner earnings: -4260000
Return on net tangible assets (%): -1.5683848949071673
Buffett classification: The Gruesome
Stock price: 16.35
Shares outstanding: 65423184
Book value: 334631000
P/B ratio: 3.1965629556137953
Market cap (USD): 1069669058.4000001
Debt to equity: 0.19369394945477256
Current ratio: 2.72314200196596
Quick ratio: 1.8213295634022155
Interest coverage ratio: -6.32225063938619
COGS to revenue (%): 79.05472852740768
R&D to revenue (%): 10.385833948179332
SG&A to revenue (%): 27.195000217004473
Free cash flow (dilution-adjusted): -16000
Buyback yield (%): 0
Retained earnings: -64924000
Inventory turnover: 0.22308361195821239
Receivables turnover: 0.8581697642370293
Capitalized R&D asset: 3904960
ROCI (R&D-adjusted, %): -0.5923109738629531
Rosenberg metric: -1.3800592300098717
FCF margin (%): -0.06944143049346817
Revenue growth (%): -17.57825076015024
Rule of 40 score: -17.64769219064371
Financial ratios for BANB.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 148.83516483516482
Shares outstanding: 74935540
Market cap (USD): 11153043447.912086
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BANB.SW — annual report dated 2022-12-31
Total revenue: 577979347.8260869
Gross profit: 186172826.0869565
Operating income: 138286956.52173913
Net income: 109439130.43478261
Capital expenditures: 150497826.0869565
Operating cash flow: 100704347.82608695
Depreciation & amortization: 36215217.391304344
Net tangible assets: 1256350000
Owner earnings: -4843478.260869563
Return on net tangible assets (%): -0.3855198201830352
Capex to operating income (%): 108.83009495063823
Buffett classification: The Gruesome
Stock price: 82.76086956521739
P/E ratio: 56.66830892296691
Shares outstanding: 74935540
Book value: 1271370652.173913
P/B ratio: 4.877987737985622
Market cap (USD): 6201730451.73913
Debt to equity: 0.0003009418968401956
Current ratio: 4.614759072702998
Quick ratio: 2.7453210341060803
Effective tax rate (%): 10.16292806538537
Interest coverage ratio: 1719.2432432432433
COGS to revenue (%): 67.78901758562911
R&D to revenue (%): 1.3546068480707714
SG&A to revenue (%): 7.101765709245668
Free cash flow (dilution-adjusted): -54834782.60869565
Buyback yield (%): 0.025273450959292943
Retained earnings: 683001086.9565217
Inventory turnover: 1.1701564052122084
Receivables turnover: 3.10883291823061
Capitalized R&D asset: 7829347.826086956
ROCI (R&D-adjusted, %): 10.766277526070462
FCF margin (%): -9.487325596484004
Rule of 40 score: -9.487325596484004
Financial ratios for BANB.SW — annual report dated 2023-12-31
Total revenue: 687280952.3809524
Gross profit: 210670238.0952381
Operating income: 154023809.52380952
Net income: 133165476.1904762
Capital expenditures: 314930952.3809524
Operating cash flow: 297457142.85714287
Depreciation & amortization: 44471428.571428575
Net tangible assets: 1555429761.904762
Owner earnings: -137294047.61904764
Return on net tangible assets (%): -8.826759715007567
Capex to operating income (%): 204.46900602875252
Buffett classification: The Gruesome
Stock price: 74.38095238095238
P/E ratio: 41.856019982299145
Shares outstanding: 74935540
Book value: 1572051190.4761906
P/B ratio: 3.54554410578233
Market cap (USD): 5573776832.380952
Debt to equity: 0.00030366756201898797
Current ratio: 5.10885745507528
Quick ratio: 3.038750607090821
Effective tax rate (%): 9.942193739533685
Interest coverage ratio: 4173.548387096774
COGS to revenue (%): 69.34728987244422
R&D to revenue (%): 1.9124708132114823
SG&A to revenue (%): 6.471325928953988
Free cash flow (dilution-adjusted): -23639285.714285716
Buyback yield (%): 0.012494733685472619
Retained earnings: 847294047.6190476
Inventory turnover: 1.1740970356728098
Receivables turnover: 3.2782860030777443
Capitalized R&D asset: 18389710.66252588
ROCI (R&D-adjusted, %): 8.773330974518585
Rosenberg metric: 3.1289211505787953
FCF margin (%): -3.4395374456969843
Revenue growth (%): 18.910987903975105
Rule of 40 score: 15.47145045827812
Financial ratios for BANB.SW — annual report dated 2024-12-31
Total revenue: 672510000
Gross profit: 202838888.8888889
Operating income: 147831111.1111111
Net income: 133608888.88888888
Capital expenditures: 304240000
Operating cash flow: 162580000
Depreciation & amortization: 48068888.88888889
Net tangible assets: 1521761111.1111112
Owner earnings: -122562222.22222224
Return on net tangible assets (%): -8.05397255372978
Capex to operating income (%): 205.80241717274967
Buffett classification: The Gruesome
Stock price: 62.46666666666666
P/E ratio: 35.03489504025015
Shares outstanding: 74935540
Book value: 1545654444.4444444
P/B ratio: 3.028473418163755
Market cap (USD): 4680973398.666666
Debt to equity: 0.00020846976721115612
Current ratio: 2.9282000363003533
Quick ratio: 1.3261337632434007
Effective tax rate (%): 11.065091820810744
Interest coverage ratio: 2660.96
COGS to revenue (%): 69.83853193426285
R&D to revenue (%): 1.8798563920569542
SG&A to revenue (%): 6.482183660218189
Free cash flow (dilution-adjusted): -155368888.88888887
Buyback yield (%): 0.025089748315574163
Retained earnings: 891088888.8888888
Inventory turnover: 0.9390020947967737
Receivables turnover: 2.5167845514763667
Capitalized R&D asset: 24032418.909592822
ROCI (R&D-adjusted, %): 8.075283248610214
Rosenberg metric: -0.5958095583129538
FCF margin (%): -23.102836967314815
Revenue growth (%): -2.149186927090186
Rule of 40 score: -25.252023894405
Financial ratios for BANB.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1521761111.1111112
Buffett classification: The Gruesome
Stock price: 62.46666666666666
Shares outstanding: 74935540
Book value: 1545654444.4444444
P/B ratio: 3.028473418163755
Market cap (USD): 4680973398.666666
Debt to equity: 0.00020846976721115612
Current ratio: 2.9282000363003533
Quick ratio: 1.3261337632434007
Buyback yield (%): 0
Retained earnings: 891088888.8888888
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BANB.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1671201250
Buffett classification: The Gruesome
Stock price: 71.57499999999999
Shares outstanding: 74935540
Market cap (USD): 5363511275.499999
Current ratio: 2.4372455471828838
Quick ratio: 0.781030810441869
Buyback yield (%): 0
Retained earnings: 1024801250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDN — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 178105000
Buffett classification: The Gruesome
Stock price: 7.79
Shares outstanding: 173711845
Market cap (USD): 1353215272.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDN — annual report dated 2022-12-31
Total revenue: 506100000
Gross profit: 311699000
Operating income: 98709000
Net income: 53992000
Capital expenditures: 263014000
Operating cash flow: 209307000
Depreciation & amortization: 177984000
Net tangible assets: 1571605000
Owner earnings: -31038000
Return on net tangible assets (%): -1.9749237244727522
Capex to operating income (%): 266.45392010860206
Buffett classification: The Gruesome
Stock price: 3.84
P/E ratio: 12.354672632982664
Shares outstanding: 173711845
Book value: 1633334000
P/B ratio: 0.40839992604084646
Market cap (USD): 667053484.8
Debt to equity: 1.217267258258262
Current ratio: 1.0946383345418624
Quick ratio: 1.0946383345418624
Effective tax rate (%): 0.10176328010805409
Interest coverage ratio: 1.3737248625704543
COGS to revenue (%): 38.41157873937957
SG&A to revenue (%): 6.916814858723573
Free cash flow (dilution-adjusted): -62646000
Buyback yield (%): 0.6005515436593669
Retained earnings: 1176195000
Receivables turnover: 2.6528772264564355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6792584857842603
FCF margin (%): -12.378186129223472
Rule of 40 score: -12.378186129223472
Financial ratios for BDN — annual report dated 2023-12-31
Total revenue: 514651000
Gross profit: 324704000
Operating income: 101045000
Net income: -196789000
Capital expenditures: 156460000
Operating cash flow: 177273000
Depreciation & amortization: 188797000
Net tangible assets: 1281928000
Owner earnings: -164452000
Return on net tangible assets (%): -12.828489587558739
Capex to operating income (%): 154.84190212281658
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 173711845
Book value: 1324157000
P/B ratio: 0.5129401679332587
Market cap (USD): 679213313.95
Debt to equity: 1.6328886982434863
Current ratio: 1.5292032856568443
Quick ratio: 1.5292032856568443
Interest coverage ratio: 1.012221387427999
COGS to revenue (%): 36.90792401064022
SG&A to revenue (%): 6.773910863866971
Free cash flow (dilution-adjusted): 10966000
Buyback yield (%): 0.0007361457582334837
Retained earnings: 979406000
Receivables turnover: 2.5902861313133854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.839653244460856
FCF margin (%): 2.1307643432151107
Revenue growth (%): 1.6895870381347562
Rule of 40 score: 3.820351381349867
Financial ratios for BDN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.33
Shares outstanding: 173711845
Market cap (USD): 752172288.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.58
Shares outstanding: 173711845
Market cap (USD): 795600250.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDN — annual report dated 2024-12-31
Total revenue: 505517000
Gross profit: 318187000
Operating income: 97238000
Net income: -195907000
Capital expenditures: 129760000
Operating cash flow: 181125000
Depreciation & amortization: 178168000
Net tangible assets: 998135000
Owner earnings: -147499000
Return on net tangible assets (%): -14.77745996283068
Capex to operating income (%): 133.445772228964
Buffett classification: The Gruesome
Stock price: 4.58
Shares outstanding: 173711845
Book value: 1044587000
P/B ratio: 0.7616409644194309
Market cap (USD): 795600250.1
Debt to equity: 2.140903534124013
Current ratio: 1.5319326809030915
Quick ratio: 1.5319326809030915
Interest coverage ratio: 0.8015926664798114
COGS to revenue (%): 37.05711182808887
SG&A to revenue (%): 8.462821230542197
Free cash flow (dilution-adjusted): 34476000
Buyback yield (%): 0
Retained earnings: 783499000
Receivables turnover: 2.565880770499708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.94586870074339
FCF margin (%): 6.819948686196507
Revenue growth (%): -1.774794958136679
Rule of 40 score: 5.0451537280598275
Financial ratios for BDN — quarterly report dated 2025-03-31
Total revenue: 121516000
Gross profit: 73925000
Operating income: 12102000
Net income: -26975000
Capital expenditures: 32811000
Operating cash flow: 6315000
Depreciation & amortization: 44353000
Net tangible assets: 960796000
Owner earnings: -15433000
Return on net tangible assets (%): -1.6062722992185647
Capex to operating income (%): 271.1204759543877
Buffett classification: The Gruesome
Stock price: 3.75
Shares outstanding: 173711845
Book value: 999396000
P/B ratio: 0.6518131138707779
Market cap (USD): 651419418.75
Debt to equity: 2.2394536299925156
Current ratio: 1.389625467714186
Quick ratio: 1.389625467714186
Interest coverage ratio: 0.3658956916099773
COGS to revenue (%): 39.164389874584415
SG&A to revenue (%): 14.376707594061688
Free cash flow (dilution-adjusted): -37564000
Buyback yield (%): 0
Retained earnings: 756524000
Receivables turnover: 0.609011176264221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3715059652155975
FCF margin (%): -30.912801606372824
Rule of 40 score: -30.912801606372824
Financial ratios for BDN — quarterly report dated 2025-06-30
Total revenue: 120571000
Gross profit: 75215000
Operating income: 22128000
Net income: -88936000
Capital expenditures: 29135000
Operating cash flow: 34389000
Depreciation & amortization: 43762000
Net tangible assets: 847791000
Owner earnings: -74309000
Return on net tangible assets (%): -8.76501401878529
Capex to operating income (%): 131.66576283441793
Buffett classification: The Gruesome
Stock price: 3.73
Shares outstanding: 173711845
Book value: 885242000
P/B ratio: 0.7319413017570338
Market cap (USD): 647945181.85
Debt to equity: 2.638852426794029
Current ratio: 2.4739594611442484
Quick ratio: 2.4739594611442484
Interest coverage ratio: 0.6597102140599845
COGS to revenue (%): 37.617669257118216
SG&A to revenue (%): 7.734032229972382
Free cash flow (dilution-adjusted): 2410000
Buyback yield (%): 0
Retained earnings: 667855000
Receivables turnover: 0.604732695018031
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6825538519813125
FCF margin (%): 1.998822270695275
Revenue growth (%): -0.7776753678527931
Rule of 40 score: 1.2211469028424817
Financial ratios for BDN — quarterly report dated 2025-09-30
Total revenue: 121417000
Gross profit: 76008000
Operating income: 25162000
Net income: -25919000
Capital expenditures: 18456000
Operating cash flow: 47463000
Depreciation & amortization: 43005000
Net tangible assets: 809943000
Owner earnings: -1370000
Return on net tangible assets (%): -0.16914770545581603
Capex to operating income (%): 73.34870042127018
Buffett classification: The Good
Stock price: 3.76
Shares outstanding: 173711845
Book value: 846902000
P/B ratio: 0.7712303633714408
Market cap (USD): 653156537.1999999
Debt to equity: 2.7076639327808887
Current ratio: 1.7346470491823947
Quick ratio: 1.7346470491823947
Interest coverage ratio: 0.7346569343065693
COGS to revenue (%): 37.39921098363491
SG&A to revenue (%): 6.4579095184364625
Free cash flow (dilution-adjusted): 26913000
Buyback yield (%): 0
Retained earnings: 641936000
Receivables turnover: 0.6112229795717005
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.796072598834397
FCF margin (%): 22.16575932530041
Revenue growth (%): 0.7016612618291297
Rule of 40 score: 22.86742058712954
Financial ratios for BDN — quarterly report dated 2025-12-31
Total revenue: 120950000
Gross profit: 74112000
Operating income: 21409000
Net income: -36684000
Capital expenditures: 32994000
Operating cash flow: 28534000
Depreciation & amortization: 45308000
Net tangible assets: 691145000
Owner earnings: -24370000
Return on net tangible assets (%): -3.526032887454875
Capex to operating income (%): 154.1127563174366
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 173711845
Book value: 797854000
P/B ratio: 0.585677157788267
Market cap (USD): 467284863.05
Debt to equity: 3.234403788161744
Current ratio: 1.4797925796247153
Quick ratio: 1.4797925796247153
Interest coverage ratio: 0.5460504501747137
COGS to revenue (%): 38.725093013642
SG&A to revenue (%): 6.114096734187681
Free cash flow (dilution-adjusted): -6012000
Buyback yield (%): 0
Retained earnings: 605252000
Receivables turnover: 0.590561753863431
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6286157739132529
FCF margin (%): -4.970649028524184
Revenue growth (%): -0.3846248877834241
Rule of 40 score: -5.355273916307608
Financial ratios for BDN — annual report dated 2025-12-31
Total revenue: 484454000
Gross profit: 299260000
Operating income: 80801000
Net income: -178247000
Capital expenditures: 113396000
Operating cash flow: 116701000
Depreciation & amortization: 176428000
Net tangible assets: 691145000
Owner earnings: -115215000
Return on net tangible assets (%): -16.670163279774865
Capex to operating income (%): 140.33984727911783
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 173711845
Book value: 797854000
P/B ratio: 0.585677157788267
Market cap (USD): 467284863.05
Debt to equity: 3.234403788161744
Current ratio: 1.4797925796247153
Quick ratio: 1.4797925796247153
Interest coverage ratio: 0.5768450961634565
COGS to revenue (%): 38.22736524004343
SG&A to revenue (%): 8.675952722033465
Free cash flow (dilution-adjusted): -14253000
Buyback yield (%): 0
Retained earnings: 605252000
Receivables turnover: 2.365440296867752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.372496760613048
FCF margin (%): -2.942074995768432
Revenue growth (%): -4.166625454732482
Rule of 40 score: -7.108700450500914
Financial ratios for BNED — annual report dated 2022-04-30
Total revenue: 1495734000
Gross profit: 342832000
Operating income: -53260000
Net income: -68857000
Capital expenditures: 33607000
Operating cash flow: 1161000
Depreciation & amortization: 42510000
Net tangible assets: 101381000
Owner earnings: -59954000
Return on net tangible assets (%): -59.13731369783293
Buffett classification: The Gruesome
Stock price: 304
Shares outstanding: 34643372
Book value: 228374000
P/B ratio: 46.115517037841435
Market cap (USD): 10531585088
Debt to equity: 2.3752134656309387
Current ratio: 1.2799769861483574
Quick ratio: 0.5012951309815552
Interest coverage ratio: -5.275356576862124
COGS to revenue (%): 77.0793469961905
SG&A to revenue (%): 23.66517041131645
Free cash flow (dilution-adjusted): -38172000
Buyback yield (%): 0.022503735004718788
Retained earnings: -491494000
Inventory turnover: 3.564213858643567
Receivables turnover: 11.186487072672744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.117034036372726
FCF margin (%): -2.552058053103025
Rule of 40 score: -2.552058053103025
Financial ratios for BNED — annual report dated 2023-04-30
Total revenue: 1543208000
Gross profit: 349439000
Operating income: -50335000
Net income: -101862000
Capital expenditures: 25092000
Operating cash flow: 91670000
Depreciation & amortization: 42189000
Net tangible assets: 20119000
Owner earnings: -84765000
Return on net tangible assets (%): -421.318156966052
Buffett classification: The Gruesome
Stock price: 156
Shares outstanding: 34643372
Book value: 130751000
P/B ratio: 41.333267294322795
Market cap (USD): 5404366032
Debt to equity: 3.5707948696377083
Current ratio: 1.1621260157763182
Quick ratio: 0.39748747524806044
Interest coverage ratio: -2.507722200079713
COGS to revenue (%): 77.35632526529153
SG&A to revenue (%): 23.17322097863671
Free cash flow (dilution-adjusted): 61863000
Buyback yield (%): 0.015987074059827487
Retained earnings: -593356000
Inventory turnover: 3.378642507811439
Receivables turnover: 17.11480791411587
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.704180113901453
FCF margin (%): 4.008727274612365
Revenue growth (%): 3.173960075788877
Rule of 40 score: 7.182687350401242
Financial ratios for BNED — annual report dated 2024-04-30
Total revenue: 1567135000
Gross profit: 344913000
Operating income: -7221000
Net income: -75749000
Capital expenditures: 14070000
Operating cash flow: -5122000
Depreciation & amortization: 40560000
Net tangible assets: -13791000
Owner earnings: -49259000
Buffett classification: The Gruesome
Stock price: 20.3
Shares outstanding: 34643372
Book value: 80400000
P/B ratio: 8.747020542288558
Market cap (USD): 703260451.6
Debt to equity: 5.148308457711443
Current ratio: 1.0970385833057743
Quick ratio: 0.3127086672887629
Interest coverage ratio: -0.2543232486880569
COGS to revenue (%): 77.99085592498413
SG&A to revenue (%): 19.881758750841506
Free cash flow (dilution-adjusted): -22572000
Buyback yield (%): 0.025026289989658786
Retained earnings: -646746000
Inventory turnover: 3.2824370488140255
Receivables turnover: 16.065599819572306
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6591990073757497
FCF margin (%): -1.4403353891017685
Revenue growth (%): 1.5504714853733261
Rule of 40 score: 0.11013609627155763
Financial ratios for BNED — quarterly report dated 2024-10-31
Capital expenditures: 0
Depreciation & amortization: 8530000
Buffett classification: The Gruesome
Stock price: 9.3
Shares outstanding: 34643372
Market cap (USD): 322183359.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNED — quarterly report dated 2025-01-31
Total revenue: 462825000
Gross profit: 93750000
Operating income: 20630000
Net income: 17942000
Capital expenditures: 2772000
Operating cash flow: -41945000
Depreciation & amortization: 7827000
Net tangible assets: 201687000
Owner earnings: 22997000
Return on net tangible assets (%): 11.402321418832152
Capex to operating income (%): 13.436742607852642
Buffett classification: The Great
Stock price: 11.19
P/E ratio: 5.401562432839148
Shares outstanding: 34643372
Book value: 283317000
P/B ratio: 1.3682882872542064
Market cap (USD): 387659332.68
Debt to equity: 1.285122318816026
Current ratio: 1.4176204582688121
Quick ratio: 0.7296599265393449
Effective tax rate (%): -29.694954460026025
Interest coverage ratio: 4.058626795199685
COGS to revenue (%): 79.74396370118295
SG&A to revenue (%): 15.46178361151623
Free cash flow (dilution-adjusted): -47278000
Buyback yield (%): 0
Retained earnings: -699199000
Inventory turnover: 1.0033083418058055
Receivables turnover: 1.306525783294424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7314175226498674
FCF margin (%): -10.215092097445039
Rule of 40 score: -10.215092097445039
Financial ratios for BNED — annual report dated 2025-04-30
Total revenue: 1610170000
Gross profit: 337804000
Operating income: 16065000
Net income: -65825000
Capital expenditures: 12894000
Operating cash flow: -85413000
Depreciation & amortization: 37939000
Net tangible assets: 193947000
Owner earnings: -40780000
Return on net tangible assets (%): -21.0263628723311
Capex to operating income (%): 80.26143790849673
Buffett classification: The Gruesome
Stock price: 10.53
Shares outstanding: 34643372
Book value: 272188000
P/B ratio: 1.340230675709436
Market cap (USD): 364794707.15999997
Debt to equity: 1.0401597425308977
Current ratio: 1.6667024800787895
Quick ratio: 0.4991816635329931
Interest coverage ratio: 0.9208414536283389
COGS to revenue (%): 79.02060030928412
SG&A to revenue (%): 17.625468118273226
Free cash flow (dilution-adjusted): -103693000
Buyback yield (%): 0.0013706339214529738
Retained earnings: -712571000
Inventory turnover: 3.902951217941049
Receivables turnover: 16.585328169420297
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1434665205650996
FCF margin (%): -6.439879018985573
Revenue growth (%): 2.746093986797564
Rule of 40 score: -3.693785032188009
Financial ratios for BNED — quarterly report dated 2025-04-30
Total revenue: 278292000
Gross profit: 56576000
Operating income: -24238000
Net income: -23193000
Capital expenditures: 3594000
Operating cash flow: 53114000
Depreciation & amortization: 8538000
Net tangible assets: 193947000
Owner earnings: -18249000
Return on net tangible assets (%): -9.409271605129236
Buffett classification: The Gruesome
Stock price: 10.53
Shares outstanding: 34643372
Book value: 272188000
P/B ratio: 1.340230675709436
Market cap (USD): 364794707.15999997
Debt to equity: 1.0401597425308977
Current ratio: 1.6667024800787895
Quick ratio: 0.4991816635329931
COGS to revenue (%): 79.67027438805285
SG&A to revenue (%): 25.971281962830407
Free cash flow (dilution-adjusted): 47087000
Buyback yield (%): 0.0002741267842905948
Retained earnings: -712571000
Inventory turnover: 0.680108343225941
Receivables turnover: 2.866507354455935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.742691660470395
FCF margin (%): 16.919997700257284
Revenue growth (%): -39.87100956084914
Rule of 40 score: -22.951011860591855
Financial ratios for BNED — quarterly report dated 2025-07-31
Total revenue: 288160000
Gross profit: 55377000
Operating income: -23166000
Net income: -18271000
Capital expenditures: 3736000
Operating cash flow: -67603000
Depreciation & amortization: 9185000
Net tangible assets: 182549000
Owner earnings: -12822000
Return on net tangible assets (%): -7.0238675643251955
Buffett classification: The Gruesome
Stock price: 8.83
Shares outstanding: 34643372
Book value: 256453000
P/B ratio: 1.192814959310283
Market cap (USD): 305900974.76
Debt to equity: 1.4296342799655297
Current ratio: 1.6111370401485214
Quick ratio: 0.549459638860367
Interest coverage ratio: -8.159915463191265
COGS to revenue (%): 80.78255136035536
SG&A to revenue (%): 23.549764019988896
Free cash flow (dilution-adjusted): -73875000
Buyback yield (%): 0
Retained earnings: -730842000
Inventory turnover: 0.5685191290862244
Receivables turnover: 1.779050958795856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.099016207799561
FCF margin (%): -25.63679900055525
Revenue growth (%): 3.5459158006698
Rule of 40 score: -22.09088319988545
Financial ratios for BNED — quarterly report dated 2025-10-31
Total revenue: 644414000
Gross profit: 129837000
Operating income: 44910000
Net income: 25004000
Capital expenditures: 4315000
Operating cash flow: 66239000
Depreciation & amortization: 7625000
Net tangible assets: 212341000
Owner earnings: 28314000
Return on net tangible assets (%): 13.334212422471403
Capex to operating income (%): 9.608105099087064
Buffett classification: The Great
Stock price: 9.13
P/E ratio: 213.42374248313092
Shares outstanding: 34643372
Book value: 283238000
P/B ratio: 1.1167074557792387
Market cap (USD): 316293986.36
Debt to equity: 1.1013670482068083
Current ratio: 1.4144577441868875
Quick ratio: 0.6957767977967556
Effective tax rate (%): 32.25867627536507
Interest coverage ratio: 15.055313442842776
COGS to revenue (%): 79.8519274876089
SG&A to revenue (%): 11.995704624666752
Free cash flow (dilution-adjusted): 60143000
Buyback yield (%): 0
Retained earnings: -705838000
Inventory turnover: 1.3627568855932204
Receivables turnover: 2.0460055498758583
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.34789397375367
FCF margin (%): 9.332975385388895
Revenue growth (%): 123.63062187673515
Rule of 40 score: 132.96359726212404
Financial ratios for BNED — quarterly report dated 2026-01-31
Total revenue: 515092000
Gross profit: 96098000
Operating income: 15077000
Net income: 6655000
Capital expenditures: 3730000
Operating cash flow: -29388000
Depreciation & amortization: 7427000
Net tangible assets: 222050000
Owner earnings: 10352000
Return on net tangible assets (%): 4.662013060121594
Capex to operating income (%): 24.739669695562778
Buffett classification: The Great
Stock price: 8.95
P/E ratio: 11.647564966190833
Shares outstanding: 34643372
Book value: 289974000
P/B ratio: 1.0692620007310998
Market cap (USD): 310058179.4
Debt to equity: 1.089794257416182
Current ratio: 1.4241714498592637
Quick ratio: 0.7807049919973509
Effective tax rate (%): 31.652459689842864
Interest coverage ratio: 3.087018837018837
COGS to revenue (%): 81.34352698158776
SG&A to revenue (%): 14.085056650074163
Free cash flow (dilution-adjusted): -33992000
Buyback yield (%): 0
Retained earnings: -699183000
Inventory turnover: 1.1230463672012159
Receivables turnover: 1.2369382241700186
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.738782924613987
FCF margin (%): -6.599209461610742
Revenue growth (%): -20.068154943871484
Rule of 40 score: -26.667364405482225
Financial ratios for CAI.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.023622047244094488
Shares outstanding: 289684072
Market cap (USD): 6842930.834645669
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAI.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -92402.20588235294
Operating income: -563838.9705882353
Net income: -368288.97058823524
Capital expenditures: 0
Operating cash flow: -165688.23529411762
Depreciation & amortization: 134991.17647058822
Net tangible assets: 6293427.205882353
Owner earnings: -233297.79411764702
Return on net tangible assets (%): -3.7070071121119472
Buffett classification: The Gruesome
Stock price: 0.007352941176470588
Shares outstanding: 289684072
Book value: 6293427.205882353
P/B ratio: 0.3384530990023321
Market cap (USD): 2130029.9411764704
Debt to equity: 0.0060187677129535586
Current ratio: 10.493786863074703
Quick ratio: 10.493786863074703
Interest coverage ratio: -136.39647812166493
Free cash flow (dilution-adjusted): -165688.23529411762
Buyback yield (%): 0
Retained earnings: -10019886.029411765
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.887430355886174
Rule of 40 score: 0
Financial ratios for CAI.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -105058.33333333333
Operating income: -753129.5454545454
Net income: -774862.8787878788
Capital expenditures: 0
Operating cash flow: -422808.3333333333
Depreciation & amortization: 115817.42424242424
Net tangible assets: 5586509.848484849
Owner earnings: -659045.4545454546
Return on net tangible assets (%): -11.797087491471949
Buffett classification: The Gruesome
Stock price: 0.015151515151515152
Shares outstanding: 289684072
Book value: 5586509.848484848
P/B ratio: 0.7856698949973239
Market cap (USD): 4389152.606060606
Debt to equity: 0.04488314856961297
Current ratio: 10.254498175465192
Quick ratio: 10.254498175465192
Interest coverage ratio: -27.827319804058785
Free cash flow (dilution-adjusted): -422808.3333333333
Buyback yield (%): 0
Retained earnings: -11098381.818181818
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.294198249358782
Rule of 40 score: 0
Financial ratios for CAI.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.014814814814814814
Shares outstanding: 289684072
Market cap (USD): 4291615.881481481
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAI.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -30916.083916083917
Operating income: -181552.44755244756
Net income: -121948.25174825176
Capital expenditures: 0
Operating cash flow: 148132.16783216785
Depreciation & amortization: 30916.083916083917
Net tangible assets: 5320718.181818182
Owner earnings: -91032.16783216785
Return on net tangible assets (%): -1.7109000086349353
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 289684072
Book value: 5320718.181818183
P/B ratio: 0.7614621455355873
Market cap (USD): 4051525.482517483
Debt to equity: 0.02351580646547662
Current ratio: 9.357884280304985
Quick ratio: 9.357884280304985
Interest coverage ratio: -48.61797752808989
Free cash flow (dilution-adjusted): 145790.2097902098
Buyback yield (%): 0
Retained earnings: -10510747.552447554
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1812274009033943
Rule of 40 score: 0
Financial ratios for CAI.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -125129.37062937063
Operating income: -680806.9930069931
Net income: -266087.4125874126
Capital expenditures: 2341.958041958042
Operating cash flow: 71526.57342657344
Depreciation & amortization: 125129.37062937063
Net tangible assets: 5320718.181818182
Owner earnings: -143300
Return on net tangible assets (%): -2.6932454436260316
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 289684072
Book value: 5320718.181818183
P/B ratio: 0.7614621455355873
Market cap (USD): 4051525.482517483
Debt to equity: 0.02351580646547662
Current ratio: 9.357884280304985
Quick ratio: 9.357884280304985
Interest coverage ratio: -35.15523778572202
Free cash flow (dilution-adjusted): 69184.61538461539
Buyback yield (%): 0
Retained earnings: -10510747.552447554
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.929345432012568
Rule of 40 score: 0
Financial ratios for CAI.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -23820.279720279723
Operating income: -120938.46153846155
Net income: 4352.447552447553
Capital expenditures: 0
Operating cash flow: -117320.97902097902
Depreciation & amortization: 23820.279720279723
Net tangible assets: 5320460.13986014
Owner earnings: 28172.727272727276
Return on net tangible assets (%): 0.5295167435173729
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
P/E ratio: 232.715353470437
Shares outstanding: 289684072
Book value: 5320460.13986014
P/B ratio: 0.7614990763983032
Market cap (USD): 4051525.482517483
Debt to equity: 0.018756724601084768
Current ratio: 10.839232768312987
Quick ratio: 10.839232768312987
Interest coverage ratio: -38.63762287756926
Free cash flow (dilution-adjusted): -117320.97902097902
Buyback yield (%): 0
Retained earnings: -10506395.104895106
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1253462987707814
Rule of 40 score: 0
Financial ratios for CAI.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -23978.83211678832
Operating income: -138363.50364963504
Net income: -15989.05109489051
Capital expenditures: 0
Operating cash flow: -107264.23357664232
Depreciation & amortization: 23978.83211678832
Net tangible assets: 5254752.554744525
Owner earnings: 7989.781021897808
Buffett classification: The Gruesome
Stock price: 0.014598540145985401
Shares outstanding: 289684072
Book value: 5254752.554744525
P/B ratio: 0.8047885244237022
Market cap (USD): 4228964.554744526
Debt to equity: 0.013877461779124939
Current ratio: 10.7590864213951
Quick ratio: 10.7590864213951
Interest coverage ratio: -56.26536064113981
Free cash flow (dilution-adjusted): -107264.23357664232
Buyback yield (%): 0
Retained earnings: -10982518.248175181
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.4548551696575873
Rule of 40 score: 0
Financial ratios for CAI.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -23521.582733812953
Operating income: -117843.88489208634
Net income: 16297.122302158274
Capital expenditures: 0
Operating cash flow: 224656.11510791368
Depreciation & amortization: 23521.582733812953
Net tangible assets: 5301575.539568346
Owner earnings: 39818.70503597123
Return on net tangible assets (%): 0.7510730487339857
Buffett classification: The Gruesome
Stock price: 0.014388489208633094
P/E ratio: 63.939449962477376
Shares outstanding: 289684072
Book value: 5301575.539568346
P/B ratio: 0.7862032923564191
Market cap (USD): 4168116.143884892
Debt to equity: 0.008780612251821434
Current ratio: 11.985136453608016
Quick ratio: 11.985136453608016
Interest coverage ratio: -68.79588408231835
Free cash flow (dilution-adjusted): 224656.11510791368
Buyback yield (%): 0
Retained earnings: -10808199.28057554
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0745494301742626
Rule of 40 score: 0
Financial ratios for CLLS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.12
Shares outstanding: 72698158
Market cap (USD): 590309042.9599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLLS — annual report dated 2022-12-31
Total revenue: 20394680.851063833
Gross profit: 11369148.936170213
Operating income: -95389361.70212767
Net income: -112913829.78723405
Capital expenditures: 2586170.2127659577
Operating cash flow: -93025531.91489363
Depreciation & amortization: 19611702.127659574
Net tangible assets: 124734042.5531915
Owner earnings: -95888297.87234044
Return on net tangible assets (%): -76.87420042643924
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 72698158
Book value: 133979787.23404258
P/B ratio: 1.1394713706576887
Market cap (USD): 152666131.8
Debt to equity: 0.6016388626420307
Current ratio: 2.282863719342805
Quick ratio: 2.282863719342805
Interest coverage ratio: -23.67731713757592
COGS to revenue (%): 44.254342496479055
R&D to revenue (%): 508.58588493036353
SG&A to revenue (%): 46.39820562307652
Free cash flow (dilution-adjusted): -102051063.82978724
Buyback yield (%): 0.3964986482589128
Retained earnings: -467557446.80851066
Receivables turnover: 1.0908728803914876
Capitalized R&D asset: 103724468.08510639
ROCI (R&D-adjusted, %): -8.3407163935498
FCF margin (%): -500.3807834750404
Rule of 40 score: -500.3807834750404
Financial ratios for CLLS — annual report dated 2023-12-31
Total revenue: 838888.8888888889
Gross profit: -7404444.444444444
Operating income: -108114444.44444445
Net income: -112287777.77777778
Capital expenditures: 1192222.2222222222
Operating cash flow: -27495555.555555556
Depreciation & amortization: 20581111.111111112
Net tangible assets: 93358888.88888888
Owner earnings: -92898888.88888888
Return on net tangible assets (%): -99.50727776918225
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 72698158
Book value: 94105555.55555558
P/B ratio: 2.379352901304681
Market cap (USD): 223910326.64000002
Debt to equity: 1.0042623531495363
Current ratio: 1.5018692311658848
Quick ratio: 1.5018692311658848
Interest coverage ratio: -18.334840776333145
COGS to revenue (%): 982.6490066225166
R&D to revenue (%): 11608.741721854305
SG&A to revenue (%): 1075.3642384105958
Free cash flow (dilution-adjusted): -34502222.222222224
Buyback yield (%): 0
Retained earnings: -450851111.1111111
Receivables turnover: 0.032641591007349764
Capitalized R&D asset: 166879838.06146574
ROCI (R&D-adjusted, %): -21.252924144405018
Rosenberg metric: -0.1809948387993741
FCF margin (%): -4112.847682119205
Revenue growth (%): -95.8867270588099
Rule of 40 score: -4208.734409178015
Financial ratios for CLLS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.12
Shares outstanding: 72698158
Market cap (USD): 154120094.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLLS — annual report dated 2024-12-31
Total revenue: 43235416.66666667
Gross profit: 33670833.333333336
Operating income: -62035416.66666667
Net income: -38292708.333333336
Capital expenditures: 2690625
Operating cash flow: 23946875
Depreciation & amortization: 20672916.666666668
Net tangible assets: 135331250
Owner earnings: -20310416.666666668
Return on net tangible assets (%): -15.007928077710556
Buffett classification: The Gruesome
Stock price: 1.8
Shares outstanding: 72698158
Book value: 136492708.3333333
P/B ratio: 0.9587082416185237
Market cap (USD): 130856684.4
Debt to equity: 0.6979997405233798
Current ratio: 1.7265335089523606
Quick ratio: 1.7265335089523606
Interest coverage ratio: -7.990607808935999
COGS to revenue (%): 22.12210282850672
R&D to revenue (%): 218.12749963860645
SG&A to revenue (%): 20.28622367850431
Free cash flow (dilution-adjusted): 16644791.666666666
Buyback yield (%): 0
Retained earnings: -343340625
Receivables turnover: 1.8017102921387336
Capitalized R&D asset: 193784985.57919624
ROCI (R&D-adjusted, %): -15.757541708159096
Rosenberg metric: 0.42178479337334274
FCF margin (%): 38.49804847491928
Revenue growth (%): 5053.890728476822
Rule of 40 score: 5092.388776951741
Financial ratios for CLLS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8
Shares outstanding: 72698158
Market cap (USD): 130856684.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLLS — quarterly report dated 2025-03-31
Total revenue: 11581521.739130434
Gross profit: 9391304.347826086
Operating income: -15411956.521739129
Net income: -19704347.826086957
Capital expenditures: 429347.8260869565
Operating cash flow: -18652173.913043477
Depreciation & amortization: 5359782.608695652
Net tangible assets: 126045652.17391303
Owner earnings: -14773913.043478262
Return on net tangible assets (%): -11.721081043790209
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 72698158
Book value: 126308695.65217388
P/B ratio: 0.7136936649891572
Market cap (USD): 90145715.92
Debt to equity: 0.7897146397714366
Current ratio: 1.6720839535942325
Quick ratio: 1.6720839535942325
Interest coverage ratio: -7.419675562532705
COGS to revenue (%): 18.91130924448616
R&D to revenue (%): 205.83763491318635
SG&A to revenue (%): 21.895823557015486
Free cash flow (dilution-adjusted): -20142391.304347824
Buyback yield (%): 0
Retained earnings: -377925000
Receivables turnover: 0.4174993142901923
Capitalized R&D asset: 23839130.43478261
ROCI (R&D-adjusted, %): 0.19795451968804717
FCF margin (%): -173.91834819333647
Rule of 40 score: -173.91834819333647
Financial ratios for CLLS — quarterly report dated 2025-06-30
Total revenue: 19676470.588235296
Gross profit: 16823529.411764707
Operating income: -11278823.529411765
Net income: -27923529.411764707
Capital expenditures: 358823.5294117647
Operating cash flow: -12129411.764705883
Depreciation & amortization: 5902352.94117647
Net tangible assets: 112891764.70588236
Owner earnings: -22380000
Return on net tangible assets (%): -19.824298130432062
Buffett classification: The Gruesome
Stock price: 1.52
Shares outstanding: 72698158
Book value: 114248235.29411763
P/B ratio: 0.9672026869870562
Market cap (USD): 110501200.16
Debt to equity: 0.975924457579471
Current ratio: 1.3775204262028764
Quick ratio: 1.3775204262028764
Interest coverage ratio: -4.665206812652068
COGS to revenue (%): 14.499252615844544
R&D to revenue (%): 137.99701046337816
SG&A to revenue (%): 13.68609865470852
Free cash flow (dilution-adjusted): -13996470.588235294
Buyback yield (%): 0
Retained earnings: -362888235.2941176
Receivables turnover: 0.5694586312563841
Capitalized R&D asset: 43125158.56777494
ROCI (R&D-adjusted, %): -0.42777542774450367
Rosenberg metric: 0.3117657787171043
FCF margin (%): -71.13303437967114
Revenue growth (%): 69.89538189747981
Rule of 40 score: -1.2376524821913364
Financial ratios for CLLS — quarterly report dated 2025-09-30
Total revenue: 41378823.52941176
Gross profit: 38605882.35294118
Operating income: 9460000
Net income: 692941.1764705883
Capital expenditures: 1389411.7647058824
Operating cash flow: -1848235.2941176472
Depreciation & amortization: 5895294.117647059
Net tangible assets: 117215294.11764707
Owner earnings: 5198823.529411765
Return on net tangible assets (%): 4.435277468308692
Capex to operating income (%): 14.687227956721802
Buffett classification: The Great
Stock price: 2.85
P/E ratio: 74.75012213709677
Shares outstanding: 72698158
Book value: 118209411.7647059
P/B ratio: 1.7527348051812335
Market cap (USD): 207189750.3
Debt to equity: 0.9233464041879813
Current ratio: 1.4887432105911413
Quick ratio: 1.4887432105911413
Effective tax rate (%): 0
Interest coverage ratio: 3.816326530612245
COGS to revenue (%): 6.70135334925509
R&D to revenue (%): 68.43227567383147
SG&A to revenue (%): 7.048220175139315
Free cash flow (dilution-adjusted): -6489411.764705883
Buyback yield (%): 0
Retained earnings: -362189411.7647059
Receivables turnover: 1.3315161839863712
Capitalized R&D asset: 54375854.21994886
ROCI (R&D-adjusted, %): 4.004880741418008
Rosenberg metric: 0.8022097053726169
FCF margin (%): -15.682929603093374
Revenue growth (%): 110.2959641255605
Rule of 40 score: 94.61303452246713